Management of Uterine Leiomyoma with Anemia

Definitive Treatment Algorithm

The American College of Radiology recommends hysterectomy as the gold standard definitive treatment with the highest satisfaction rates (up to 90% at 2 years) and eliminates recurrence risk 2, 3, 1
Hysterectomy allows estrogen-only hormone replacement therapy at menopause, which is curative 3
Myomectomy is the appropriate surgical option for women desiring fertility preservation, but carries a 27% recurrence rate at 10 years, with higher rates in women with multiple fibroids 1
The American College of Radiology suggests that hysteroscopic myomectomy is first-line for intracavitary and submucosal fibroids that protrude significantly into the endometrial cavity 3, 4
Abdominal myomectomy is required for intramural and subserosal fibroids 4
Preoperative GnRH agonist therapy for 3-6 months reduces fibroid size and corrects anemia 4
Women should wait 2-3 months after myomectomy before attempting pregnancy 1
Recurrence risk necessitates counseling that myomectomy provides only an interval of symptom relief, not cure 2

Uterine artery embolization (UAE) is appropriate for women who wish to preserve their uterus but have completed childbearing, with 95% symptomatic relief at 12 months and major complications in <3% of patients 5, 1, 6
UAE achieves 42% fibroid volume reduction and controls symptoms in 80% of patients 5, 6
Symptom improvement includes menorrhagia (83%), dysmenorrhea (77%), and urinary frequency (86%) 5, 6
Reintervention rates are 28% at 5 years and 35% at 10 years 6
Higher failure rates occur in women <40 years of age due to increased collateral vessel recruitment 1, 6
Amenorrhea risk is age-dependent: <3% for women <45 years, up to 20% for women >45 years 6
The role of UAE in women desiring future fertility remains unclear—counsel that pregnancy is possible but outcomes are uncertain 6

GnRH agonists reduce bleeding but cause significant hypoestrogenic side effects, including 1% bone loss per month, limiting use to 6 months maximum 4, 1
Add-back therapy with GnRH agonists mitigates hypoestrogenic effects while maintaining efficacy 1
Oral contraceptives and progestins may manage bleeding in women with smaller fibroids but have limited effect on fibroid size 1

Location of fibroids significantly impacts treatment success: intracavitary and submucosal fibroids are best treated with hysteroscopic resection 3, 4
Cervical fibroids and multiple submucosal fibroids have higher UAE failure rates 1
Pedunculated subserosal fibroids were previously considered UAE contraindications but recent data show good outcomes 1
Morcellation warning: when specimen removal requires morcellation, patients must be informed that fibroids may rarely contain unexpected malignancy (approximately 1 in 350 cases) and laparoscopic power morcellation may spread cancer, worsening prognosis 5
Coexisting conditions: for adenomyosis with fibroids, UAE shows 65-88% long-term symptomatic relief 1
When endometriosis coexists, surgical methods addressing both conditions simultaneously may be more appropriate 1